SecBot SecBot
8-K ·Filed Sep 15, 2026

ABEO

ABEONA THERAPEUTICS INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001493152-26-042702
Actionable Insight • Neutral

Monitor the conference presentation for any pipeline updates or strategic commentary that could move the stock. Without access to the presentation content, the filing itself provides no actionable trading signal.

DirectionNeutral
Confidencelow
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$5.47
T+0 close · Sep 15, 2026 · via day close
Latest settled
−17.37%
T+20 · $4.52 · next T+60 in 22d
Vs SPY
−20.34%
α at T+20
Latest observation
−53.72%
T+43 · FF3 residual α
  1. T+0 · Sep 15 $5.47entry
  2. T+1 · 2mo ago −1.55%α −1.88% · $5.39
  3. T+5 · 8w ago +1.83%α +1.01% · $5.57
  4. T+20 · 5w ago −17.37%α −20.34% · $4.52
  5. T+44 · todayOpen
  6. T+60 · in 22d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Abeona Therapeutics filed an 8-K furnishing an updated investor presentation for the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. The filing is a routine Regulation FD disclosure of a conference presentation with no new material financial data or guidance provided. The presentation content was not available for review, limiting the analysis to the filing's metadata.

Key Facts

  • Filed 8-K on September 15, 2026 to furnish an updated investor presentation.
  • Presentation to be used at the H.C. Wainwright 28th Annual Global Investment Conference.
  • No financial results, guidance, or material corporate events disclosed in the filing text.
  • Presentation content (Exhibit 99.1) was not available for analysis.

Financial Impact

No financial data disclosed in the filing.

Risk Factors

  • Lack of access to the investor presentation limits visibility into any forward-looking statements or pipeline updates.
  • Routine conference presentations rarely contain material new information, limiting near-term catalysts.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (ABEO), Batch item 10001493152-26-042702
Document: 0001493152-26-042702-index-headers.html0001493152-26-042702
Document: 0001493152-26-042702-index.html0001493152-26-042702
Document: 0001493152-26-042702.txt0001493152-26-042702
8-K Filing (ABEO), Batch item 50001493152-26-042702

Track record

29 reports on ABEO

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +15.24% at T+20 after the Sep 29, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $2.59 Now $2.60 +0.39% settles Nov 18
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $2.30 Now $2.60 +13.04% settles Nov 17
  3. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $2.29 to $2.42 Now $2.60 +13.54% ▲ +5.68% +6.04% vs SPY
  4. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  5. Nov 9, 20267d ago 8-K Bearish 6/10 Entry $2.54 to $2.46 Now $2.60 −2.36% ▲ +3.35% +2.98% vs SPY
  6. Nov 9, 20267d ago Press Release Mixed 6/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  7. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $4.17 to $2.54 Now $2.60 −37.65% ▼ −39.09% −41.46% vs SPY
  8. Oct 23, 202624d ago SC 13D Bullish 6/10 Entry $4.40 to $4.31 Now $2.60 −40.91% ▼ −2.05% −2.76% vs SPY
  9. Sep 29, 20266w ago Insider Cluster Bearish 4/10 Entry $5.25 to $5.01 Now $2.60 +50.48% ▲ +4.57% +4.75% vs SPY
  10. Sep 18, 20268w ago Press Release Bullish 6/10 Entry $5.57 to $5.67 Now $2.60 −53.32% ▲ +1.80% +0.24% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens in 8h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 15, 2026